GlassScriptPhysician profile
Susan E Matthews
NPI 1194705244
$2,168.15
in general payments reported to CMS, 2019-2025
44 companies · $314 in 2025
The $314 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $68.65 · 2020: $231 · 2021: $578 · 2022: $313 · 2023: $238 · 2024: $425 · 2025: $314.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $978.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $977.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $277.21 | 2020-2025 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $262.49 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $152.90 | 2019-2025 | Fasenra, Airsupra |
| Exact Sciences Corporation | $95.64 | 2024-2025 | Cologuard Collection Kit |
| Amgen INC. | $94.49 | 2020-2024 | Repatha, Otezla |
| Alexion Pharmaceuticals, INC. | $73.35 | 2020-2022 | |
| Edwards Lifesciences Corporation | $70.65 | 2024-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Alkermes, INC. | $70.33 | 2023-2024 | Aristada, Lybalvi |
| Sanofi Pasteur INC. | $64.68 | 2022-2024 | |
| Hologic Sales and Service, LLC | $60.81 | 2022-2023 | Aptima, Thinprep 2000 Processor |
| Esperion Therapeutics, INC. | $54.73 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $51.26 | 2019-2025 | Trintellix |
| Allergan, INC. | $50.01 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $45.45 | 2020-2021 | |
| Pfizer INC. | $45.17 | 2021-2024 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Matthews listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.